You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

omalizumab

Showing 1 - 25 of 256
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic Trial in Copenhagen (omalizumab 300 mg every four weeks, omalizumab

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Chronic Urticaria, Idiopathic
  • omalizumab 300 mg every four weeks
  • omalizumab 300 mg every six weeks
  • Copenhagen, Copenhagen N, Denmark
    Department of Dermatology, Bispebjerg Hospital
Jun 21, 2023

Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Sep 20, 2023

Allergic Asthma Trial (omalizumab, )

Completed
Has Results
  • Allergic Asthma
  • omalizumab
  • placebo
  • (no location specified)
Dec 9, 2022

Chronic Rhinosinusitis With Nasal Polyps, Nasal Polyps Trial in Baltimore (Omalizumab)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Nasal Polyps
  • Omalizumab
  • Baltimore, Maryland
  • +1 more
Jan 18, 2023

Asthma in Children, Atopy, Viral Upper Respiratory Infection Trial in Washington (Omalizumab, Placebo)

Recruiting
  • Asthma in Children
  • +2 more
  • Omalizumab
  • Placebo
  • Washington, District of Columbia
    Children's National Hospital
Aug 26, 2022

Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)

Active, not recruiting
  • Covid19
  • Omalizumab
  • Placebo
  • Niagara, Ontario, Canada
  • +2 more
Nov 14, 2022

Food Allergy Trial in Odense C (Omalizumab, Placebo)

Recruiting
  • Food Allergy
  • Omalizumab
  • Placebo
  • Odense C, Funen, Denmark
    Odense Research Center for Anaphylaxis, Allergy Center, Odense U
Sep 20, 2022

Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria

Recruiting
  • Spontaneous Urticaria, Chronic
    • Lille, France
      Hop Claude Huriez Chu Lille
    Jan 25, 2023

    Omalizumab in Children With Allergic Asthma.

    Completed
    • Allergic Asthma
    • Omalizumab
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jun 29, 2022

    Xolair® in Pediatric Chronic Spontaneous Urticaria in China

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • Xolair
    • (no location specified)
    Sep 19, 2023

    Nasal Polyps Trial in Shiraz (Omalizumab, SNOT22 score)

    Not yet recruiting
    • Nasal Polyps
    • Omalizumab
    • SNOT22 score
    • Shiraz, Fars, Iran, Islamic Republic of
      Imam Reza Allergy and Immunology clinic, Shiraz University of Me
    May 31, 2022

    Allergic Asthma, Uncontrolled Moderate to Severe Trial in Iran, Islamic Republic of (Omalizumab (CinnaGen), Omalizumab

    Completed
    • Allergic Asthma
    • Uncontrolled Moderate to Severe
    • Omalizumab (CinnaGen)
    • Omalizumab (Genentech, Inc., USA and Novartis Pharmaceuticals Corp, Switzerland)
    • Ahvaz, Iran, Islamic Republic of
    • +21 more
    Apr 3, 2023

    Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)

    Not yet recruiting
    • Chronic Idiopathic Urticaria
    • Omalizumab Injection
    • Xolair Prefilled Syringe
    • (no location specified)
    Mar 7, 2023

    Asthma, Allergic Trial (omalizumab)

    Not yet recruiting
    • Asthma, Allergic
    • omalizumab
    • (no location specified)
    Aug 30, 2023

    Food Allergy Trial (Drug: Chinese Herbal Medication, Drug: Placebo, Drug: Omalizumab)

    Completed
    • Food Allergy
    • Drug: Chinese Herbal Medication
    • +2 more
    • (no location specified)
    Oct 24, 2023

    XOLAIR Outcomes in Pediatric Allergic Asthma United States

    Completed
    • Asthma
    • Omalizumab
    • East Hanover, New Jersey
      Novartis Investigational Site
    Dec 15, 2021

    Food IgE-mediated Allergy, Immunotherapy, Omalizumab Trial in Toronto, Montréal, Sherbrooke (Omalizumab 16mg/kg, Omalizumab

    Recruiting
    • Food IgE-mediated Allergy
    • +3 more
    • Omalizumab 16mg/kg
    • +3 more
    • Toronto, Ontario, Canada
    • +2 more
    Jan 31, 2022

    Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)

    Completed
    • Healthy Volunteers
    • CMAB007
    • Xolair
    • Shanghai, China
      Shanghai Xuhui Central Hospital
    Jun 8, 2023

    Fluctuation Analyses of Asthma Patients With Biologics Use

    Not yet recruiting
    • Asthma
    • Biological Drug
    • (no location specified)
    Sep 7, 2023

    Asthma, Infertility, Female Trial in Copenhagen (Omalizumab Injection, NaCl)

    Recruiting
    • Asthma
    • Infertility, Female
    • Omalizumab Injection
    • NaCl
    • Copenhagen, Denmark
      Charlotte Suppli Ulrik
    Dec 16, 2021

    Omalizumab on Corticosteroid Use, Emergency Room Visits and

    Withdrawn
    • Asthma
      • (no location specified)
      Nov 23, 2021

      Asthma Trial in Paris (Attempt to withdrawal OMA treatment, Continuation of OMA treatment)

      Recruiting
      • Asthma
      • Attempt to withdrawal OMA treatment
      • Continuation of OMA treatment
      • Paris, Île De France, France
        Höpital Bichat-Claude Bernard
      Feb 9, 2022

      Asthma Trial in Shanghai (Omalizumab)

      Completed
      • Asthma
      • Omalizumab
      • Shanghai, Shanghai, China
        Shanghai Xuhui Central Hospital
      Oct 8, 2021

      Chronic Rhinosinusitis With Nasal Polyps Trial in Ghent (Mepolizumab)

      Recruiting
      • Chronic Rhinosinusitis With Nasal Polyps
      • Mepolizumab
      • Ghent, Belgium
        Ghent University Hospital
      Jul 6, 2023

      Chronic Urticaria, Idiopathic Trial in Aurora (Omalizumab)

      Recruiting
      • Chronic Urticaria, Idiopathic
      • Omalizumab
      • Aurora, Colorado
        University of Colorado Anschutz
      Mar 23, 2022